We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals
IONS

390 hedge funds and large institutions have $7.29B invested in Ionis Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 116 increasing their positions, 131 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 43

6% more funds holding

Funds holding: 369 → 390 (+21)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

0% less capital invested

Capital invested by funds: $7.3B → $7.29B (-$9.2M)

0.96% less ownership

Funds ownership: 86.79% → 85.83% (-0.96%)

11% less repeat investments, than reductions

Existing positions increased: 116 | Existing positions reduced: 131

13% less call options, than puts

Call options by funds: $89M | Put options by funds: $103M

Holders
390
Holders Change
+21
Holders Change %
+5.69%
% of All Funds
7.68%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
69
Increased
116
Reduced
131
Closed
43
Calls
$89M
Puts
$103M
Net Calls
-$13.9M
Net Calls Change
-$11.1M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$74.1M
2
Rockefeller Capital Management
Rockefeller Capital Management
New York
+$29M
3
Citadel Advisors
Citadel Advisors
Florida
+$24.9M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$22.3M
5
JP Morgan Chase
JP Morgan Chase
New York
+$19.2M

Top Sellers

Rank Fund Capital Flow
1
ClearBridge Investments
ClearBridge Investments
New York
-$80M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$60M
3
WRF
Waddell & Reed Financial
Kansas
-$59M
4
APG Asset Management
APG Asset Management
Netherlands
-$26.3M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$22.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
TI
376
tru Independence
Oregon
$2K +$2.15K +36 New
HIA
377
Harbor Investment Advisory
Maryland
$2K +$2.26K +38 New
LP
378
LMR Partners
United Kingdom
$1.74K +$1.48M +24,781 +615%
QCG
379
Quadrant Capital Group
Ohio
$1K -$11.6K -195 -89%
PCG
380
Private Capital Group
Connecticut
$1K – – –
SFSIG
381
San Francisco Sentry Investment Group
California
$1K – – –
VFA
382
Valeo Financial Advisors
Indiana
$1K – – –
LWA
383
Lowe Wealth Advisors
Maryland
$1K +$596 +10 New
AF
384
Allworth Financial
California
$1K +$1.01K +17 +243%
NIM
385
Nicollet Investment Management
Minnesota
$625 -$17.3K -290 -3%
Balyasny Asset Management
386
Balyasny Asset Management
Illinois
– -$15.2M -253,265 Closed
DCM
387
Decatur Capital Management
Georgia
– -$3.85M -64,176 Closed
HF
388
HRT Financial
New York
– -$3.28M -54,813 Closed
PC
389
Polar Capital
United Kingdom
– -$3M -50,000 Closed
KWILP
390
Kiwi Wealth Investments Limited Partnership
New Zealand
– -$2.71M -45,197 Closed
AL
391
AJO LP
Pennsylvania
– -$1.84M -30,748 Closed
CM
392
Castleark Management
Illinois
– -$1.63M -27,125 Closed
Connor, Clark & Lunn Investment Management (CC&L)
393
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$1.13M -18,825 Closed
Schroder Investment Management Group
394
Schroder Investment Management Group
United Kingdom
– -$1.1M -18,647 Closed
OAM
395
Oxford Asset Management
United Kingdom
– -$965K -16,113 Closed
AIM
396
Allen Investment Management
New York
– -$939K -15,680 Closed
WC
397
Wexford Capital
Florida
– -$922K -15,385 Closed
CRC
398
Curi RMB Capital
Illinois
– -$789K -13,178 Closed
AC
399
Allstate Corporation
Illinois
– -$726K -12,110 Closed
WMSA
400
Weiss Multi-Strategy Advisers
New York
– -$599K -10,000 Closed
14 15
16
17 18

IONS Hedge Fund Activity: Q4 2019 in Review

390 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q4 2019, worth a combined $7.29B — down 0.13% from $7.3B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new IONS positions and 43 closed out — a net gain of 26 holders — while 116 added to existing stakes and 131 trimmed.

The largest buyer was BVF Inc, adding an estimated $74.1M. The largest seller was ClearBridge Investments, cutting an estimated $80M.

  • 390 institutional investors held Ionis Pharmaceuticals (IONS) as of Q4 2019, up from 369 in Q3 2019.
  • Funds reported $7.29B of Ionis Pharmaceuticals stock for Q4 2019, down 0.13% quarter-over-quarter.
  • 69 funds opened new Ionis Pharmaceuticals positions in Q4 2019 and 43 closed out, a net change of +26 holders.
  • The largest Ionis Pharmaceuticals buyer in Q4 2019 was BVF Inc, an estimated $74.1M added.
  • The largest Ionis Pharmaceuticals seller in Q4 2019 was ClearBridge Investments, an estimated $80M sold.

Based on aggregated 13F filings for Q4 2019.